Health Condition 1: N00-N99- Diseases of the genitourinary system
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: Not applicable: Not applicable
Control Intervention2: Dexmedetomidine: Dexmedetomidine is selective alpha-2 agonist used intrathecal for subarachnoid blo
Sponsors
Vijayanagar institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients belonging to ASA 1 to 2 Patients undergoing elective infra umbilical surgeries
Exclusion criteria
Exclusion criteria: Patient refusal for spinal anaesthesia History of allergy to study drugs Any contra indication for spinal anaesthesia Deformity of lumbosacral spine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the time taken for two segment regression of sensory blockade between the two groupsTimepoint: from intrathecal injection of drug to two segment regression of maximal dermatomal achieved | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset of sensory blockade Onset of motor blockade Duration of sensory blockade Duration of motor blockade Intra and immediate postoperative hemodynamics Duration of analgesia Need for the first rescue analgesiaTimepoint: Intra and post operative | — |
Countries
India
Contacts
Public ContactDR BALA SUBRAMANYA H
Vijayanagar institute of medical sciences, Ballari
Outcome results
None listed